• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

One Drop partners with Fitbit to bring diabetes data to people’s wrists

November 1, 2017 By Sarah Faulkner

One DropOne Drop announced yesterday that it landed a multi-part collaboration with Fitbit (NYSE:FIT).

The group’s first initiative will be to integrate Fitbit’s data onto One Drop’s mobile app for diabetes management, the company said, in the hopes to helping One Drop users better understand how physical activity impacts blood glucose management.

The data from Fitbit will also be integrated into One Drop reports, which physicians and healthcare professionals can access.

New York-based One Drop added that it plans to analyze Fitbit’s data in search of larger insights and trends in the diabetes community.

“We strive to provide our community with the most comprehensive set of data and tools to manage their diabetes or prediabetes. Working with Fitbit, the leading global wearables brand, was a natural next step for One Drop,” foudner & CEO Jeff Dachis said in prepared remarks. “One Drop is among the top health and fitness apps in nearly 120 countries with over 600,000 downloads worldwide. By integrating Fitbit data and creating an app for Fitbit Ionic, we will be able to provide our users and their healthcare providers with more data and deeper insights to better manage their diabetes.”

The company also announced that as part of the collaboration, One Drop is slated to develop an app for Fitbit’s Ionic smartwatch using the Fitbit software development kit made available to developers last month.

“Our mission is to help make the world healthier, and our new Ionic smartwatch is the health platform that allows us to deliver our most advanced health and fitness features to the market,” Adam Pellegrini, GM of Fitbit Health Solutions, added. “This holistic experience brings the power of Fitbit data together with One Drop’s sophisticated care management technology to provide meaningful insights on the role of physical activity and how it can improve the health of those living with diabetes.”

In September, Fitbit partnered with Dexcom to integrate the company’s CGM data with Fitbit’s new smartwatch so CGM users on Android or iOS devices can see their activity and glucose levels on their wrists.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Big Data, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: fitbit, onedrop

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS